In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
about
A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in HumansAtovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosisEffect of atovaquone and atovaquone drug combinations on prophylaxis of Pneumocystis carinii pneumonia in SCID miceEffects of 2',3'-dideoxyinosine on Toxoplasma gondii cysts in miceIn vitro and in vivo effects of rifabutin alone or combined with atovaquone against Toxoplasma gondiiClinically used antimicrobial drugs against experimental pneumocystosis, singly and in combination: analysis of drug interactions and efficaciesGreat efficacy of sulfachloropyrazine-sodium against acute murine toxoplasmosisCiprofloxacin Derivatives Affect Parasite Cell Division and Increase the Survival of Mice Infected with Toxoplasma gondiiIn vitro and in vivo activities of 1-hydroxy-2-alkyl-4(1H)quinolone derivatives against Toxoplasma gondii.Drug evaluation of concurrent Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium complex infections in a rat modelToxoplasma gondii infection can induce retinal DNA damage: an experimental studyAntiparasitic agent atovaquoneActivity of oral atovaquone alone and in combination with antimony in experimental visceral leishmaniasisAtovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis.Targeting Toxoplasma gondii CPSF3 as a new approach to control toxoplasmosis.Population pharmacokinetics of pyrimethamine and sulfadoxine in children treated for congenital toxoplasmosis.In vivo effect of anti-TNF agent (etanercept) in reactivation of latent toxoplasmosis.Effects of Thymus vulgaris ethanolic extract on chronic toxoplasmosis in a mouse model.Effect of Nigella sativa oil on experimental toxoplasmosis.In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone.In vitro antagonistic and indifferent activity of combination of 3-deoxyanthocyanidins against Toxoplasma gondii.Preparation of (131)I-Pyrimethamine and evaluation for scintigraphy of experimentally Toxoplasma gondii-infected rats.SDS-coated atovaquone nanosuspensions show improved therapeutic efficacy against experimental acquired and reactivated toxoplasmosis by improving passage of gastrointestinal and blood-brain barriers.The role of apolipoprotein E in uptake of atovaquone into the brain in murine acute and reactivated toxoplasmosis.
P2860
Q26782186-4A4FB111-FD7E-46F1-AA33-B5F5972057E6Q28365205-D55280B0-540B-40E8-9855-C23D2CFB9024Q28368166-3C790E39-459A-4851-A21A-50259822F4E8Q28379020-00549BBF-B277-4D95-8A47-9000EEE44BECQ28379243-1D48E0F6-099D-46BB-BBCF-D098B77F0D4DQ28379455-DB781C22-71B9-48B5-B644-08FD13A79BA8Q28396159-127F7FD1-1E1E-42BF-BB2D-38743236AE4AQ28547065-3451BAA1-75ED-49B9-BB39-B24EF98E67BBQ33558897-3908C95A-44EB-4440-97D0-7EBAA094C746Q33695186-CE34B08B-C631-446F-8A42-C89401689930Q33794962-69A48874-18E4-4689-B4ED-8E8E5A45AE6AQ34107885-2F401AE2-0D87-427E-9612-07D4B48F519EQ35122890-B467B327-61BB-408F-981E-38EFDAEEC57AQ37625142-3517FC39-3306-4514-B809-8380BC6E3126Q37672675-D71C5AB3-88E0-46A3-9C4F-5019F04D3A02Q40165651-AD11C956-3143-4330-9FC3-D9EF26716783Q40439491-FC63507D-DD44-4339-8740-98EDD63B05F9Q40706096-FA6CCF58-258F-41A3-B4AB-209C1122FED3Q40962264-9976544E-381C-45F1-9C53-36FA31140F08Q41831157-E8997C4D-2C81-48E2-8C04-6DFDC225BC65Q43167893-D110DA49-233D-40BB-9F5A-48D314107318Q44119074-0BE2A4CC-B33D-4F9D-8A2C-4771092673DEQ44164523-A1D957F5-4FAD-40D6-BE77-6ECCA5AA92F2Q46102626-6F61B956-F91D-4325-B951-F1DCFEA6F4BA
P2860
In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
In vitro and in vivo activitie ...... ine against Toxoplasma gondii.
@en
In vitro and in vivo activitie ...... ine against Toxoplasma gondii.
@nl
type
label
In vitro and in vivo activitie ...... ine against Toxoplasma gondii.
@en
In vitro and in vivo activitie ...... ine against Toxoplasma gondii.
@nl
prefLabel
In vitro and in vivo activitie ...... ine against Toxoplasma gondii.
@en
In vitro and in vivo activitie ...... ine against Toxoplasma gondii.
@nl
P2093
P2860
P356
P1476
In vitro and in vivo activitie ...... ine against Toxoplasma gondii.
@en
P2093
P2860
P304
P356
10.1128/AAC.37.11.2371
P407
P577
1993-11-01T00:00:00Z